These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35809560)

  • 1. Promising potent in vitro activity of curcumin and quercetin nano-niosomes against Trichomonas vaginalis.
    Hezarjaribi HZ; Mollarostami F; Ebrahimnejad P; Esboei BR; Fakhar M; Sadeghi-Ghadi Z
    Ann Parasitol; 2022; 68(2):263-273. PubMed ID: 35809560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacy of curcumin on Trichomonas vaginalis.
    Wachter B; Syrowatka M; Obwaller A; Walochnik J
    Wien Klin Wochenschr; 2014 Apr; 126 Suppl 1():S32-6. PubMed ID: 24619489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoliposomes increases Anti-Trichomonas vaginalis and apoptotic activities of metronidazole.
    Ebrahimi M; Montazeri M; Ahmadi A; Nami S; Hamishehkar H; Shahrivar F; Bakhtiar NM; Nissapatorn V; Spotin A; Ahmadpour E
    Acta Trop; 2021 Dec; 224():106156. PubMed ID: 34599888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparasitic activity of synthetic curcumin monocarbonyl analogues against Trichomonas vaginalis.
    Carapina da Silva C; Pacheco BS; das Neves RN; Dié Alves MS; Sena-Lopes Â; Moura S; Borsuk S; de Pereira CMP
    Biomed Pharmacother; 2019 Mar; 111():367-377. PubMed ID: 30594049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescence-based assay for Trichomonas vaginalis drug screening.
    Chen Q; Li J; Wang Z; Meng W; Wang H; Wang Z
    Parasit Vectors; 2023 Sep; 16(1):329. PubMed ID: 37723582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.
    Ramírez-Ledesma MG; Rodríguez MC; Alva-Murillo N; Avila EE
    Parasitol Res; 2022 Dec; 121(12):3503-3512. PubMed ID: 36171407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Hydroalcoholic Extract of
    Rahdar M; Ramezaninia ST; Karami MF; Hasanzadeh A; Yousefi HA; Zargar A
    Turkiye Parazitol Derg; 2023 Dec; 47(4):214-219. PubMed ID: 38149441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in vitro activity of ceragenins against Trichomonas vaginalis.
    Polat ZA; Cetin A; Savage PB
    Acta Parasitol; 2016 Mar; 61(2):376-81. PubMed ID: 27078662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
    Butler SE; Augostini P; Secor WE
    Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
    Küng E; Pietrzak J; Klaus C; Walochnik J
    Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vivo evaluation of novel hyaluronan containing niosomes tailored by Box-Behnken design to co-encapsulate curcumin and quercetin.
    Sadeghi Ghadi Z; Dinarvand R; Asemi N; Talebpour Amiri F; Ebrahimnejad P
    Eur J Pharm Sci; 2019 Mar; 130():234-246. PubMed ID: 30711688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
    Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
    J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
    Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
    Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Trichomonas vaginalis activity of 1,10-phenanthroline-5,6-dione-based metallodrugs and synergistic effect with metronidazole.
    Vargas Rigo G; Petro-Silveira B; Devereux M; McCann M; Souza Dos Santos AL; Tasca T
    Parasitology; 2019 Aug; 146(9):1179-1183. PubMed ID: 30207253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amiodarone, amioder, and dronedarone on Trichomonas vaginalis.
    de Souza TG; Benaim G; de Souza W; Benchimol M
    Parasitol Res; 2022 Jun; 121(6):1761-1773. PubMed ID: 35435511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-
    Vazini H
    J Parasit Dis; 2017 Dec; 41(4):1034-1039. PubMed ID: 29114138
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of in vitro activity of metronidazole and garlic-based product (Tomex®) on Trichomonas vaginalis.
    Ibrahim AN
    Parasitol Res; 2013 May; 112(5):2063-7. PubMed ID: 23455944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.